Nuvectis Pharma (NVCT) Institutional Ownership

→ A.I. Pioneer Issues Urgent Warning to Americans (From TradeSmith) (Ad)

Free NVCT Stock Alerts

$6.82

+0.10 (+1.49%)

(As of 04/19/2024 ET)

Compare

Current Institutional Ownership Percentage: 96.77%
Number of Institutional Buyers (last 12 months): 29
Total Institutional Inflows (last 12 months): $14.93M

Number of Institutional Sellers (last 12 months): 2
Total Institutional Outflows (last 12 months): $1.28M

Get NVCT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Nuvectis Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NVCT Institutional Buying and Selling by Quarter

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

Nuvectis Pharma Major Shareholders & Ownership History

Export to Excel

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/18/2024	Blue Zone Wealth Advisors LLC	14,350	$118K	0.0%	N/A	0.081%
3/11/2024	Vanguard Group Inc.	294,283	$2.45M	0.0%	+1.1%	1.656%
2/16/2024	GSA Capital Partners LLP	27,313	$228K	0.0%	N/A	0.158%
2/15/2024	Barclays PLC	10,254	$86K	0.0%	+638.2%	0.059%
2/15/2024	Vanguard Group Inc.	294,283	$2.45M	0.0%	+1.1%	1.698%
2/13/2024	Northern Trust Corp	61,574	$514K	0.0%	+12.6%	0.355%
Get the Latest News and Ratings for NVCT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Nuvectis Pharma and its competitors with MarketBeat's FREE daily newsletter.
2/12/2024	Edmond DE Rothschild Holding S.A.	19,170	$160K	0.0%	N/A	0.111%
1/30/2024	Strs Ohio	6,200	$51K	0.0%	+59.0%	0.036%
1/8/2024	Baldwin Brothers LLC MA	142,040	$1.19M	0.1%	+22.0%	0.820%
12/18/2023	Vanguard Group Inc.	291,134	$3.75M	0.0%	+9.5%	1.680%
11/14/2023	Tower Research Capital LLC TRC	7,282	$94K	0.0%	+1,241.1%	0.042%
11/8/2023	Charles Schwab Investment Management Inc.	19,920	$257K	0.0%	+10.7%	0.116%
11/2/2023	Forbes J M & Co. LLP	34,000	$438K	0.1%	-49.3%	0.197%
10/26/2023	Strs Ohio	3,900	$50K	0.0%	+178.6%	0.023%
10/10/2023	Baldwin Brothers LLC MA	116,380	$1.50M	0.1%	+29.2%	0.675%
8/21/2023	California State Teachers Retirement System	2,279	$36K	0.0%	N/A	0.013%
8/15/2023	Wells Fargo & Company MN	2,845	$45K	0.0%	+11,280.0%	0.017%
8/15/2023	Royal Bank of Canada	2,692	$43K	0.0%	N/A	0.016%
8/15/2023	Citadel Advisors LLC	28,028	$448K	0.0%	N/A	0.163%
8/14/2023	Marshall Wace LLP	41,775	$667K	0.0%	N/A	0.242%
8/14/2023	State Street Corp	105,240	$1.68M	0.0%	+685.4%	0.611%
8/14/2023	Nuveen Asset Management LLC	10,669	$170K	0.0%	N/A	0.062%
8/11/2023	Renaissance Technologies LLC	36,400	$581K	0.0%	N/A	0.227%
8/11/2023	BlackRock Inc.	314,491	$5.02M	0.0%	+2,219.9%	1.964%
8/11/2023	Geode Capital Management LLC	112,536	$1.80M	0.0%	+221.3%	0.703%
8/11/2023	JPMorgan Chase & Co.	5,460	$87K	0.0%	N/A	0.034%
8/11/2023	Northern Trust Corp	53,634	$857K	0.0%	N/A	0.335%
8/10/2023	MetLife Investment Management LLC	3,970	$63K	0.0%	N/A	0.025%
8/10/2023	Hollencrest Capital Management	3,040	$49K	0.0%	N/A	0.019%
8/10/2023	Charles Schwab Investment Management Inc.	17,995	$287K	0.0%	N/A	0.112%
8/10/2023	Citigroup Inc.	2,039	$33K	0.0%	N/A	0.013%
8/4/2023	American International Group Inc.	3,298	$53K	0.0%	N/A	0.021%
8/3/2023	Forbes J M & Co. LLP	67,000	$1.07M	0.1%	N/A	0.418%
8/3/2023	Bank of New York Mellon Corp	19,150	$306K	0.0%	N/A	0.120%
8/2/2023	Bank of Montreal Can	11,012	$200K	0.0%	N/A	0.069%
7/14/2023	Baldwin Brothers LLC MA	90,061	$1.44M	0.1%	-37.4%	0.563%
5/16/2023	Jane Street Group LLC	11,086	$145K	0.0%	N/A	0.075%
5/16/2023	State Street Corp	13,400	$176K	0.0%	+14.5%	0.091%
5/16/2023	Geode Capital Management LLC	35,022	$459K	0.0%	+11.6%	0.237%
5/12/2023	BlackRock Inc.	13,556	$178K	0.0%	+33.4%	0.092%
A.I. Pioneer Issues Urgent Warning to Americans (Ad) With artificial intelligence creeping into every facet of our lives, what should you be doing to "A.I.-Proof" your future? It's the question on many of our minds. Click here to see Louis' new video for yourself.
5/11/2023	Edmond DE Rothschild Holding S.A.	24,570	$322K	0.0%	N/A	0.167%
4/21/2023	Baldwin Brothers LLC MA	143,800	$1.89M	0.2%	+7.9%	0.975%
2/15/2023	Virtu Financial LLC	12,418	$93K	0.0%	N/A	0.085%
11/15/2022	Vanguard Group Inc.	27,061	$192K	0.0%	+16.4%	0.185%
11/15/2022	BlackRock Inc.	14,003	$100K	0.0%	+94.5%	0.096%
11/10/2022	Tower Research Capital LLC TRC	4,052	$29K	0.0%	+216.8%	0.028%
11/4/2022	Ronit Capital LLP	562,547	$3.99M	5.4%	+34.2%	3.843%
10/14/2022	Baldwin Brothers LLC MA	133,000	$943K	0.1%	+9.9%	0.908%
8/15/2022	State Street Corp	11,700	$131K	0.0%	N/A	0.092%
8/15/2022	Citadel Advisors LLC	35,069	$393K	0.0%	N/A	0.276%
8/4/2022	Ronit Capital LLP	419,282	$4.70M	6.7%	-23.8%	3.297%
7/18/2022	Baldwin Brothers LLC MA	121,000	$1.36M	0.2%	N/A	0.951%
5/17/2022	Virtu Financial LLC	11,365	$84K	0.0%	N/A	0.089%
5/12/2022	BlackRock Inc.	7,872	$59K	0.0%	N/A	0.062%
5/11/2022	Ronit Capital LLP	550,000	$4.08M	5.1%	N/A	4.325%

(Data available from 1/1/2016 forward)

NVCT Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of NVCT shares?: During the previous two years, 31 institutional investors and hedge funds held shares of Nuvectis Pharma. The most heavily invested institutionals were BlackRock Inc. ($5.02M), Ronit Capital LLP ($3.99M), Vanguard Group Inc. ($2.45M), Geode Capital Management LLC ($1.80M), State Street Corp ($1.68M), Baldwin Brothers LLC MA ($1.19M), and Marshall Wace LLP ($667K).Learn more on NVCT's institutional investors.
What percentage of Nuvectis Pharma stock is owned by institutional investors?: 96.77% of Nuvectis Pharma stock is owned by institutional investors. Learn more on NVCT's institutional investor holdings.
Which institutional investors have been buying Nuvectis Pharma stock?: Of the 31 institutional investors that purchased Nuvectis Pharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Ronit Capital LLP ($693.27K), BlackRock Inc. ($319.01K), Baldwin Brothers LLC MA ($195.48K), State Street Corp ($105.24K), Geode Capital Management LLC ($81.17K), Forbes J M & Co. LLP ($67K), and Citadel Advisors LLC ($63.10K).

How much institutional buying is happening at Nuvectis Pharma?: Institutional investors have bought a total of 1,928,048 shares in the last 24 months. This purchase volume represents approximately $22.32M in transactions.
Which Nuvectis Pharma major shareholders have been selling company stock?: The following institutional investors have sold Nuvectis Pharma stock in the last 24 months: Ronit Capital LLP ($130.72K), Baldwin Brothers LLC MA ($53.74K), and Forbes J M & Co. LLP ($33K).
How much institutional selling is happening at Nuvectis Pharma?: Institutional investors have sold a total of 217,457 shares in the last 24 months. This volume of shares sold represents approximately $2.75M in transactions.

Related Companies:

This page (NASDAQ:NVCT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Nuvectis Pharma (NVCT) Institutional Ownership

NVCT Institutional Buying and Selling by Quarter

Nuvectis Pharma Major Shareholders & Ownership History

NVCT Institutional Ownership - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Nuvectis Pharma (NVCT) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Nuvectis Pharma (NASDAQ:NVCT)

NVCT Institutional Buying and Selling by Quarter

Nuvectis Pharma Major Shareholders & Ownership History

NVCT Institutional Ownership - Frequently Asked Questions